As marked heterogeneity and complexity of GBM often impede therapeutic advances, exploring the molecular mechanism and microenvironmental regulation of GBM is highly significant for understanding GBM pathogenesis and identifying new treatment targets.
← all excerpts
A fibroblast-specific gene signature as a therapeutic target for glioblastoma developed based on the characteristics of tumor microenvironment.
1
—
—